AlTi Global Q4 2025 slides: revenue surges 71%, UHNW focus pays off

AlTi Global reported Q4 revenue of $88M (up 71% sequential, +54% YoY) and FY2025 revenue of $255M (+29% YoY); Q4 adjusted EBITDA was $11M and FY adjusted EBITDA $35M (+45% YoY). Assets under management reached $50B (+10% YoY) and assets under advisement $93B (+23% YoY); GAAP net loss was $155M driven by non‑cash items, while adjusted net income was +$11M. The company secured strategic commitments of up to $450M ( $250M funded from Allianz X and $115M from Constellation to date) to fuel M&A and international expansion, and guided FY2026 quarterly EPS of $0.09 for Q1–Q3 and $0.13 for Q4 with quarterly revenue ranges of $63M–$102M.

Analysis

The quarter should be read as proof of concept rather than steady-state performance: strategic capital from institutional partners is effectively an acquisition war chest and distribution optionality. If management deploys remaining tranches into bolt-on deals that are margin-accretive, the equity can re-rate quickly because the business model has high operating leverage — 300–500bps of incremental EBITDA margin expansion would drive outsized EPS upside over 12–24 months.

Countervailing risks are front-loaded and time-sensitive. Incentive fees remain lumpy and can flip the headline narrative quarter-to-quarter, FX translation can erase realized performance gains in reporting, and the acquisition/integration cycle is a multi-quarter execution risk that can produce further non-cash write-downs if deal multiples or credit underwriting deteriorate.

Second-order competitive dynamics favor specialized independents if they can scale global product distribution, but this is gated by talent and access to liquid alternatives for UHNW clients. The partnership with a large insurance/asset manager creates a distribution moat if commercialized, yet also raises margin pressure if product flows get preference or internalized — the real arbitrage will be whether the firm can preserve pricing power while using partner balance sheets to accelerate M&A.

Key Decisions for Investors

• Accumulate ALTI (equity) sized 1–3% NAV on any >15% post-earnings pullback; time horizon 12–18 months. Risk: stop at -30% from entry; Reward: target ~+100% if management deploys capital into 2–3 accretive tuck-ins and EBITDA margin expands ~300–500bps.
• Relative/value pair: Long ALTI / Short NTRS (notional-neutral) for 6–12 months to isolate small-cap M&A multiple re-rate vs. large-cap custodian exposure. Risk: widen in spread >25% -> cut; Reward: expect 40–60% relative outperformance if ALTI executes M&A and converts recurring revenue.
• Tactical options: Buy long-dated (12–24 month) ALTI call exposure or call-spread using no more than 2% NAV to capture binary upside from tranche deployment and incentive-fee realization. Note liquidity risk in options; use spreads to cap premium and preserve time-value decay.
• Event short (contrarian hedge): If price pops >30% on headline EPS swing, consider a small short (0.5–1% NAV) or buy protective puts — target a 40% downside reversion window if incentive fees normalize and additional impairments surface. Tight stop: widen of >20% against position.